Alphatec Plunges On Gloomy Outlook For Spine Market, 2Q Miss

NEW YORK (Dow Jones)–Shares of Alphatec Holdings Inc. (ATEC) plunged as the medical-device maker’s second-quarter results missed estimates, leading it to slash its full-year revenue guidance.

The company, which makes products for the surgical treatment of spine disorders, in March completed the purchase of France-based Scient’x S.A., though difficulties related to the international integration remain.

Chief Executive Dirk Kuyper said several factors contributed to the lower-than-expected results…



Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Themed By Curio Display Cabinets